ArticleThe Journal of investigative dermatology2022

Vemurafenib Drives Epithelial-to-Mesenchymal Transition Gene Expression in BRAF Inhibitor‒Resistant BRAF

Jana Jandova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.